Qualifyze

About:

Qualifyze provides digital solutions for supply chain risk management in Life Sciences.

Website: https://www.qualifyze.com

Twitter/X: qualifyze

Top Investors: Insight Partners, HV Capital, Cherry Ventures, HarbourVest Partners, APX

Description:

Qualifyze supports pharma companies with fast, flexible, and reliable supply chain compliance assessments. Qualifyze connects customers, suppliers, and auditors via their data and application platform. They capture and convert proprietary raw audit data to generate unique insights into supplier compliance levels across the supply chain and help their partners in healthcare track, monitor, and forecast quality and sustainability compliance efforts. Through this cloud-based platform, their customers can access and drill down into supplier compliance information at any time across multiple sites, shaping a new way to optimize supplier risk mitigation processes in a streamlined, cost-effective manner. With a global network of over 200 local expert auditors, 1,000+ pharma clients, and the world’s largest database of supplier compliance data from 2,000+ suppliers, Qualifyze is a leading provider of structured and analyzable GxP audit data resulting from onsite inspections in the pharmaceutical supply chain.

Total Funding Amount:

$85.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Frankfurt, Hessen, Germany

Founded Date:

2019-01-01

Contact Email:

info(AT)qualifyze.com

Founders:

Dr. David Schneider, Florian Hildebrand

Number of Employees:

101-250

Last Funding Date:

2024-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai